ICD-10-CM Billable Code

T46.0X

Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code T46.0X covers cases involving poisoning, adverse effects, or underdosing related to cardiac-stimulant glycosides and similar medications. These drugs are used primarily to treat heart conditions like heart failure and certain arrhythmias. However, misuse, overdose, or adverse reactions can lead to serious health issues. Recognizing the symptoms, causes, and treatment options associated with these reactions is crucial for effective management and prevention.

Causes & Symptoms

Clinical Causes: Accidental ingestion of excess medication Intentional overdose or misuse of cardiac-stimulant drugs Incorrect dosing during medication administration Sensitivity or allergic reaction to the medication Interaction with other drugs that increase toxicity Metabolic disturbances affecting drug processing

Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Confusion or mental disturbances Irregular heartbeat (arrhythmias) Palpitations or a rapid heartbeat Visual disturbances such as blurred vision or seeing yellow halos Weakness or fatigue Dizziness or lightheadedness Respiratory distress in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a detailed medical history review, including medication dosages and timing, along with physical examinations. Blood tests are crucial to measure serum levels of glycosides to identify toxicity. An electrocardiogram (ECG) can detect arrhythmias related to overdose. Additional assessments may include kidney function tests and checking electrolyte levels to evaluate overall impact on the body and guide treatment strategies.

Treatment Protocols: Treatment focuses on stabilizing the patient and removing or neutralizing the toxic effects. Common approaches include: - **Cessation of the offending drug** and discontinuing any causative medications. - **Supportive care** such as antiarrhythmic agents or medications to counteract specific symptoms. - **Administration of activated charcoal** if the overdose was recent, to limit drug absorption. - **Use of digoxin-specific antibody fragments** (Digibind or DigiFab) in cases of severe glycoside toxicity. - **Electrolyte correction** to address imbalances that may exacerbate toxicity. - **Monitoring** of heart rhythm, vital signs, and serum drug levels until stabilization. In all cases, management should be conducted under medical supervision, with emergency interventions as needed for life-threatening symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T46.0X a billable ICD-10 code?
Yes, T46.0X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T46.0X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

glycosides drugs underdosing effect adverse action poisoning similar